AU2002356646A1 - Pharmaceutical compositions for the pulmonary delivery of aztreonam - Google Patents
Pharmaceutical compositions for the pulmonary delivery of aztreonamInfo
- Publication number
- AU2002356646A1 AU2002356646A1 AU2002356646A AU2002356646A AU2002356646A1 AU 2002356646 A1 AU2002356646 A1 AU 2002356646A1 AU 2002356646 A AU2002356646 A AU 2002356646A AU 2002356646 A AU2002356646 A AU 2002356646A AU 2002356646 A1 AU2002356646 A1 AU 2002356646A1
- Authority
- AU
- Australia
- Prior art keywords
- aztreonam
- pharmaceutical compositions
- pulmonary delivery
- pulmonary
- delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2002/014061 WO2004052333A1 (en) | 2002-12-11 | 2002-12-11 | Pharmaceutical compositions for the pulmonary delivery of aztreonam |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002356646A1 true AU2002356646A1 (en) | 2004-06-30 |
Family
ID=32479695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002356646A Abandoned AU2002356646A1 (en) | 2002-12-11 | 2002-12-11 | Pharmaceutical compositions for the pulmonary delivery of aztreonam |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002356646A1 (en) |
| WO (1) | WO2004052333A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW465235B (en) | 1998-09-17 | 2001-11-21 | United Video Properties Inc | Electronic program guide with digital storage |
| US7138419B2 (en) * | 2000-12-27 | 2006-11-21 | Corus Pharma, Inc. | Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate |
| US7214364B2 (en) | 2000-12-27 | 2007-05-08 | Corus Pharma, Inc. | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
| DK1353647T3 (en) | 2000-12-27 | 2011-06-14 | Gilead Sciences Inc | Inhalable aztreonam for treating and preventing bacterial lung infections |
| WO2004013133A1 (en) | 2002-08-05 | 2004-02-12 | TEVA Gyógyszergyár Részvénytársaság | Preparation of aztreonam |
| WO2004103999A1 (en) | 2003-05-15 | 2004-12-02 | TEVA Gyógyszergyár Részvénytársaság | AZTREONAM β POLYMORPH WITH VERY LOW RESIDUAL SOLVENT CONTENT |
| BRPI0411691A (en) * | 2003-07-02 | 2006-12-26 | Teva Gyogyszergyar Reszvenytar | Aztreonam l-lysine and its preparation methods |
| AU2014271333B2 (en) * | 2003-07-03 | 2016-10-27 | Gilead Sciences, Inc. | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
| WO2006122253A1 (en) | 2005-05-09 | 2006-11-16 | Sicor, Inc. | Process for making aztreonam |
| KR101424518B1 (en) | 2005-09-29 | 2014-08-06 | 노바르티스 아게 | Antibiotic formulations, unit doses, kits, and methods |
| US8337814B2 (en) | 2005-12-15 | 2012-12-25 | Topical Sinus Therapeutics, Inc. | Treatment of active infections, sinusitis, rhinitis, and related neurological disorders and related compositions |
| SG11201700484SA (en) * | 2014-08-08 | 2017-02-27 | Shenzhen Hightide Biopharmaceutical Ltd | Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof |
| CN104784159A (en) * | 2015-04-15 | 2015-07-22 | 苏州惠仁生物科技有限公司 | Method for preparing aztreonam powder aerosol |
| CN110898040B (en) * | 2018-09-18 | 2022-05-17 | 北京盈科瑞创新药物研究有限公司 | Freeze-dried powder for aztreonam solution for inhalation and preparation method thereof |
| CN113876722B (en) * | 2021-11-04 | 2022-12-02 | 海南皇隆制药股份有限公司 | Aztreonam for injection and preparation method thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1181075A (en) * | 1981-07-13 | 1985-01-15 | David M. Floyd | CRYSTALLINE ANHYDROUS FORM OF [3-S-[3.alpha.(Z),4 .beta.]]-3-[[(2-AMINO-4-THIAZOLYL) [(1-CARBOXY-1-METHYLETHOXY)IMINO]ACETYL] AMINO]-4-METHYL-2-OXO-1-AZETIDINESULFONIC ACID |
| US4826973A (en) * | 1984-07-20 | 1989-05-02 | E. R. Squibb & Sons, Inc. | Delta form of aztreonam and preparation thereof |
| US4675398A (en) * | 1985-08-16 | 1987-06-23 | E. R. Squibb & Sons, Inc. | Copper-mediated oximation reaction |
| CA1339136C (en) * | 1987-07-01 | 1997-07-29 | Sailesh Amilal Varia | Amorphous form of aztreonam |
| AU1572101A (en) * | 1999-11-08 | 2001-06-06 | Pharmacia & Upjohn Company | Admixture of linezolid and other antibacterial agents |
| DK1353647T3 (en) * | 2000-12-27 | 2011-06-14 | Gilead Sciences Inc | Inhalable aztreonam for treating and preventing bacterial lung infections |
-
2002
- 2002-12-11 AU AU2002356646A patent/AU2002356646A1/en not_active Abandoned
- 2002-12-11 WO PCT/EP2002/014061 patent/WO2004052333A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004052333A1 (en) | 2004-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003278393A1 (en) | New use for pharmaceutical composition | |
| AU2003291103A1 (en) | Pharmaceutical composition | |
| IL163366A (en) | Glucocorticoid mimetics, pharmaceutical compositions thereof and uses thereof for the preparation of pharmaceutical compositions | |
| AU2003246810A1 (en) | Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives | |
| GB0213739D0 (en) | Pharmaceutical compositions | |
| AU2003245504A1 (en) | Pharmaceutical compositions for drugs having ph-dependentsolubility | |
| AU2003250372A1 (en) | Pharmaceutical composition | |
| AU2002356646A1 (en) | Pharmaceutical compositions for the pulmonary delivery of aztreonam | |
| AU2001232017A1 (en) | Pharmaceutical composition for pulmonary delivery | |
| GB0213481D0 (en) | Pharmaceutical compositions | |
| AU2003265373A1 (en) | Preparation of aztreonam | |
| AU2003216503A1 (en) | Stable pharmaceutical compositions | |
| AU2003274410A1 (en) | Pharmaceutical compositions of ganciclovir | |
| AU2003238896A1 (en) | Stabilized pharmaceutical compositions containing benzimidazole compounds | |
| AU2003280960A1 (en) | Pharmaceutical compositions for otic use | |
| AU2003205460A1 (en) | Liquid mucoadhesive pharmaceutical composition | |
| SI1653963T1 (en) | Nasal pharmaceutical piribedil composition | |
| AUPS188302A0 (en) | Pharmaceutical composition | |
| AU2003201624A1 (en) | Compositions for pulmonary administration | |
| AU2002236132A1 (en) | Modified release oral pharmaceutical composition | |
| HK1078272A (en) | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation | |
| HK1073611A (en) | Pharmaceutical compositions | |
| HK1067075A (en) | Microparticle pharmaceutical compositions for intratumoral delivery | |
| HK1071299A (en) | Stable pharmaceutical compositions | |
| AU2001290947A1 (en) | Compositions for drug delivery |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |